{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:36:22Z","timestamp":1792629382422,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS122257"],"award-info":[{"award-number":["NS122257"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS099623"],"award-info":[{"award-number":["NS099623"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS114765"],"award-info":[{"award-number":["NS114765"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57142-9","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T06:48:17Z","timestamp":1740552497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Dysregulation of mitochondrial \u03b1-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson\u2019s disease models"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9907-8216","authenticated-orcid":false,"given":"Ge","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0030-8465","authenticated-orcid":false,"given":"Han-Xiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4716-1886","authenticated-orcid":false,"given":"Dimitri","family":"Krainc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"57142_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier, D. J., Obeso, J. A. & Halliday, G. M. Selective neuronal vulnerability in Parkinson disease. Nat. Rev. Neurosci. 18, 101\u2013113 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"57142_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","volume":"18","author":"H Ye","year":"2023","unstructured":"Ye, H., Robak, L. A., Yu, M., Cykowski, M. & Shulman, J. M. Genetics and Pathogenesis of Parkinson\u2019s Syndrome. Annu Rev. Pathol. 18, 95\u2013121 (2023).","journal-title":"Annu Rev. Pathol."},{"key":"57142_CR3","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/nature04788","volume":"441","author":"J Park","year":"2006","unstructured":"Park, J. et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157\u20131161 (2006).","journal-title":"Nature"},{"key":"57142_CR4","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nature04779","volume":"441","author":"IE Clark","year":"2006","unstructured":"Clark, I. E. et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441, 1162\u20131166 (2006).","journal-title":"Nature"},{"key":"57142_CR5","doi-asserted-by":"publisher","unstructured":"Narendra, D. P. et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. Plos Biol. 8. https:\/\/doi.org\/10.1371\/journal.pbio.1000298 (2010).","DOI":"10.1371\/journal.pbio.1000298"},{"key":"57142_CR6","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla, L. F. et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science 357, 1255\u20131261 (2017).","journal-title":"Science"},{"key":"57142_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tins.2018.11.001","volume":"42","author":"M Nguyen","year":"2019","unstructured":"Nguyen, M., Wong, Y. C., Ysselstein, D., Severino, A. & Krainc, D. Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson\u2019s Disease. Trends Neurosci. 42, 140\u2013149 (2019).","journal-title":"Trends Neurosci."},{"key":"57142_CR8","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1016\/j.neuron.2023.08.018","volume":"111","author":"P Song","year":"2023","unstructured":"Song, P. et al. Parkinson\u2019s disease-linked parkin mutation disrupts recycling of synaptic vesicles in human dopaminergic neurons. Neuron 111, 3775\u20133788 e3777 (2023).","journal-title":"Neuron"},{"key":"57142_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41531-023-00531-y","volume":"9","author":"K Kalecky","year":"2023","unstructured":"Kalecky, K. & Bottiglieri, T. Targeted metabolomic analysis in Parkinson\u2019s disease brain frontal cortex and putamen with relation to cognitive impairment. NPJ Parkinsons Dis. 9, 84 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"57142_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42862-7","volume":"14","author":"S Schmidt","year":"2023","unstructured":"Schmidt, S. et al. A reversible state of hypometabolism in a human cellular model of sporadic Parkinson\u2019s disease. Nat. Commun. 14, 7674 (2023).","journal-title":"Nat. Commun."},{"key":"57142_CR11","doi-asserted-by":"publisher","unstructured":"Peng, W., Schroeder, L. F., Song, P. P., Wong, Y. C. & Krainc, D. Parkin regulates amino acid homeostasis at mitochondria-lysosome (M\/L) contact sites in Parkinson\u2019s disease. Sci. Adv. 9. https:\/\/doi.org\/10.1126\/sciadv.adh3347 (2023).","DOI":"10.1126\/sciadv.adh3347"},{"key":"57142_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S1474-4422(14)70266-2","volume":"14","author":"M Funayama","year":"2015","unstructured":"Funayama, M. et al. CHCHD2 mutations in autosomal dominant late-onset Parkinson\u2019s disease: a genome-wide linkage and sequencing study. Lancet Neurol. 14, 274\u2013282 (2015).","journal-title":"Lancet Neurol."},{"key":"57142_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15500","volume":"8","author":"H Meng","year":"2017","unstructured":"Meng, H. et al. Loss of Parkinson\u2019s disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c. Nat. Commun. 8, 15500 (2017).","journal-title":"Nat. Commun."},{"key":"57142_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mito.2014.10.003","volume":"20","author":"S Aras","year":"2015","unstructured":"Aras, S. et al. MNRR1 (formerly CHCHD2) is a bi-organellar regulator of mitochondrial metabolism. Mitochondrion 20, 43\u201351 (2015).","journal-title":"Mitochondrion"},{"key":"57142_CR15","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1093\/nar\/gks1454","volume":"41","author":"S Aras","year":"2013","unstructured":"Aras, S. et al. Oxygen-dependent expression of cytochrome c oxidase subunit 4-2 gene expression is mediated by transcription factors RBPJ, CXXC5 and CHCHD2. Nucleic Acids Res. 41, 2255\u20132266 (2013).","journal-title":"Nucleic Acids Res."},{"key":"57142_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.15252\/emmm.201505496","volume":"8","author":"EC Genin","year":"2016","unstructured":"Genin, E. C. et al. CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis. EMBO Mol. Med. 8, 58\u201372 (2016).","journal-title":"EMBO Mol. Med."},{"key":"57142_CR17","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1038\/s41418-019-0482-7","volume":"27","author":"W Liu","year":"2020","unstructured":"Liu, W. et al. Chchd2 regulates mitochondrial morphology by modulating the levels of Opa1. Cell Death Differ. 27, 2014\u20132029 (2020).","journal-title":"Cell Death Differ."},{"key":"57142_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/hmg\/ddab057","volume":"30","author":"S Sato","year":"2021","unstructured":"Sato, S. et al. Homeostatic p62 levels and inclusion body formation in CHCHD2 knockout mice. Hum. Mol. Genet 30, 443\u2013453 (2021).","journal-title":"Hum. Mol. Genet"},{"key":"57142_CR19","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/hmg\/ddy413","volume":"28","author":"W Zhou","year":"2019","unstructured":"Zhou, W. et al. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction. Hum. Mol. Genet. 28, 1100\u20131116 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"57142_CR20","doi-asserted-by":"publisher","first-page":"8493","DOI":"10.1096\/fj.201903133RR","volume":"34","author":"T Liu","year":"2020","unstructured":"Liu, T. et al. CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia. FASEB J. 34, 8493\u20138509 (2020).","journal-title":"FASEB J."},{"key":"57142_CR21","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1039\/c0mb00058b","volume":"6","author":"G Cavallaro","year":"2010","unstructured":"Cavallaro, G. Genome-wide analysis of eukaryotic twin CX9C proteins. Mol. Biosyst. 6, 2459\u20132470 (2010).","journal-title":"Mol. Biosyst."},{"key":"57142_CR22","doi-asserted-by":"publisher","unstructured":"Imai, Y., Meng, H., Shiba-Fukushima, K. & Hattori, N. Twin CHCH proteins, CHCHD2, and CHCHD10: key molecules of parkinson\u2019s disease, amyotrophic lateral sclerosis, and frontotemporal dementia. Int. J. Mol. Sci. 20. https:\/\/doi.org\/10.3390\/ijms20040908 (2019).","DOI":"10.3390\/ijms20040908"},{"key":"57142_CR23","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1093\/brain\/awu138","volume":"137","author":"S Bannwarth","year":"2014","unstructured":"Bannwarth, S. et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain 137, 2329\u20132345 (2014).","journal-title":"Brain"},{"key":"57142_CR24","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/brain\/awac197","volume":"145","author":"EC Genin","year":"2022","unstructured":"Genin, E. C. et al. CHCHD10 and SLP2 control the stability of the PHB complex: a key factor for motor neuron viability. Brain 145, 3415\u20133430 (2022).","journal-title":"Brain"},{"key":"57142_CR25","doi-asserted-by":"publisher","unstructured":"Johnson, J. O. et al. Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis. Brain 137. https:\/\/doi.org\/10.1093\/brain\/awu265 (2014).","DOI":"10.1093\/brain\/awu265"},{"key":"57142_CR26","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1093\/brain\/awu227","volume":"137","author":"K Muller","year":"2014","unstructured":"Muller, K. et al. Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron disease. Brain 137, e309 (2014).","journal-title":"Brain"},{"key":"57142_CR27","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000003","volume":"1","author":"M Auranen","year":"2015","unstructured":"Auranen, M. et al. CHCHD10 variant p.(Gly66Val) causes axonal Charcot-Marie-Tooth disease. Neurol. Genet. 1, e1 (2015).","journal-title":"Neurol. Genet."},{"key":"57142_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/ane.12470","volume":"133","author":"P Pasanen","year":"2016","unstructured":"Pasanen, P. et al. Intrafamilial clinical variability in individuals carrying the CHCHD10 mutation Gly66Val. Acta Neurol. Scand. 133, 361\u2013366 (2016).","journal-title":"Acta Neurol. Scand."},{"key":"57142_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/jnnp-2016-314154","volume":"88","author":"S Penttila","year":"2017","unstructured":"Penttila, S. et al. CHCHD10 mutations and motor neuron disease: the distribution in Finnish patients. J. Neurol. Neurosurg. Psychiatry 88, 272\u2013277 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"57142_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10048-014-0421-1","volume":"16","author":"S Ajroud-Driss","year":"2015","unstructured":"Ajroud-Driss, S. et al. Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy. Neurogenetics 16, 1\u20139 (2015).","journal-title":"Neurogenetics"},{"key":"57142_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/hmg\/ddx397","volume":"27","author":"SR Burstein","year":"2018","unstructured":"Burstein, S. R. et al. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions. Hum. Mol. Genet. 27, 160\u2013177 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"57142_CR32","first-page":"3881","volume":"27","author":"X Huang","year":"2018","unstructured":"Huang, X. et al. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10. Hum. Mol. Genet. 27, 3881\u20133900 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"57142_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0802-8","volume":"9","author":"S Atlante","year":"2018","unstructured":"Atlante, S. et al. alpha-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis. Cell Death Dis. 9, 756 (2018).","journal-title":"Cell Death Dis."},{"key":"57142_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17862-6","volume":"11","author":"PSJ Bailey","year":"2020","unstructured":"Bailey, P. S. J. et al. ABHD11 maintains 2-oxoglutarate metabolism by preserving functional lipoylation of the 2-oxoglutarate dehydrogenase complex. Nat. Commun. 11, 4046 (2020).","journal-title":"Nat. Commun."},{"key":"57142_CR35","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.1523\/JNEUROSCI.20-24-08972.2000","volume":"20","author":"L Tretter","year":"2000","unstructured":"Tretter, L. & Adam-Vizi, V. Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J. Neurosci. 20, 8972\u20138979 (2000).","journal-title":"J. Neurosci."},{"key":"57142_CR36","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1046\/j.1471-4159.1999.0730220.x","volume":"73","author":"C Chinopoulos","year":"1999","unstructured":"Chinopoulos, C., Tretter, L. & Adam-Vizi, V. Depolarization of in situ mitochondria due to hydrogen peroxide-induced oxidative stress in nerve terminals:: Inhibition of \u03b1-ketoglutarate dehydrogenase. J. Neurochem. 73, 220\u2013228 (1999).","journal-title":"J. Neurochem."},{"key":"57142_CR37","doi-asserted-by":"publisher","first-page":"6689","DOI":"10.1073\/pnas.96.12.6689","volume":"96","author":"DT Lucas","year":"1999","unstructured":"Lucas, D. T. & Szweda, L. I. Declines in mitochondrial respiration during cardiac reperfusion: age-dependent inactivation of alpha-ketoglutarate dehydrogenase. Proc. Natl Acad. Sci. USA 96, 6689\u20136693 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"57142_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40170-017-0165-0","volume":"5","author":"R Vatrinet","year":"2017","unstructured":"Vatrinet, R. et al. The alpha-ketoglutarate dehydrogenase complex in cancer metabolic plasticity. Cancer Metab. 5, 3 (2017).","journal-title":"Cancer Metab."},{"key":"57142_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101418","volume":"30","author":"D Shin","year":"2020","unstructured":"Shin, D., Lee, J., You, J. H., Kim, D. & Roh, J. L. Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer. Redox Biol. 30, 101418 (2020).","journal-title":"Redox Biol."},{"key":"57142_CR40","doi-asserted-by":"publisher","first-page":"8312","DOI":"10.1074\/jbc.M113.545301","volume":"289","author":"CL Quinlan","year":"2014","unstructured":"Quinlan, C. L. et al. The 2-oxoacid dehydrogenase complexes in mitochondria can produce superoxide\/hydrogen peroxide at much higher rates than complex I. J. Biol. Chem. 289, 8312\u20138325 (2014).","journal-title":"J. Biol. Chem."},{"key":"57142_CR41","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.neuroscience.2008.02.071","volume":"153","author":"NY Calingasan","year":"2008","unstructured":"Calingasan, N. Y. et al. Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases. Neuroscience 153, 986\u2013996 (2008).","journal-title":"Neuroscience"},{"key":"57142_CR42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt, T. M., Proneth, B. & Conrad, M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic. Biol. Med. 133, 144\u2013152 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"57142_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0891-5849(95)00017-R","volume":"19","author":"L Packer","year":"1995","unstructured":"Packer, L., Witt, E. H. & Tritschler, H. J. Alpha-Lipoic acid as a biological antioxidant. Free Radic. Bio Med. 19, 227\u2013250 (1995).","journal-title":"Free Radic. Bio Med."},{"key":"57142_CR44","doi-asserted-by":"publisher","first-page":"7522","DOI":"10.1074\/jbc.TM117.000259","volume":"293","author":"A Solmonson","year":"2018","unstructured":"Solmonson, A. & DeBerardinis, R. J. Lipoic acid metabolism and mitochondrial redox regulation. J. Biol. Chem. 293, 7522\u20137530 (2018).","journal-title":"J. Biol. Chem."},{"key":"57142_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0009-2797(01)00268-X","volume":"138","author":"P Arivazhagan","year":"2001","unstructured":"Arivazhagan, P., Ramanathan, K. & Panneerselvam, C. Effect of DL-alpha-lipoic acid on mitochondrial enzymes in aged rats. Chem. Biol. Interact. 138, 189\u2013198 (2001).","journal-title":"Chem. Biol. Interact."},{"key":"57142_CR46","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.clnu.2005.04.005","volume":"24","author":"S Savitha","year":"2005","unstructured":"Savitha, S., Sivarajan, K., Haripriya, D., Kokilavani, V. & Panneerselvam, C. Efficacy of levo carnitine and alpha lipoic acid in ameliorating the decline in mitochondrial enzymes during aging. Clin. Nutr. 24, 794\u2013800 (2005).","journal-title":"Clin. Nutr."},{"key":"57142_CR47","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1471-4159.2009.05942.x","volume":"109","author":"A Ambrus","year":"2009","unstructured":"Ambrus, A., Tretter, L. & Adam-Vizi, V. Inhibition of the alpha-ketoglutarate dehydrogenase-mediated reactive oxygen species generation by lipoic acid. J. Neurochem. 109, 222\u2013229 (2009).","journal-title":"J. Neurochem."},{"key":"57142_CR48","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.freeradbiomed.2014.03.022","volume":"71","author":"S Hiller","year":"2014","unstructured":"Hiller, S. et al. alpha-Lipoic acid protects mitochondrial enzymes and attenuates lipopolysaccharide-induced hypothermia in mice. Free Radic. Biol. Med. 71, 362\u2013367 (2014).","journal-title":"Free Radic. Biol. Med."},{"key":"57142_CR49","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.1074\/jbc.M608126200","volume":"282","author":"Z Qin","year":"2007","unstructured":"Qin, Z. et al. Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation. J. Biol. Chem. 282, 5862\u20135870 (2007).","journal-title":"J. Biol. Chem."},{"key":"57142_CR50","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.freeradbiomed.2010.11.027","volume":"50","author":"T Nasstrom","year":"2011","unstructured":"Nasstrom, T. et al. The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of alpha-synuclein oligomers with distinct biochemical, morphological, and functional properties. Free Radic. Biol. Med. 50, 428\u2013437 (2011).","journal-title":"Free Radic. Biol. Med."},{"key":"57142_CR51","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1089\/ars.2011.4429","volume":"18","author":"EJ Bae","year":"2013","unstructured":"Bae, E. J. et al. Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of alpha-synuclein. Antioxid. Redox Signal. 18, 770\u2013783 (2013).","journal-title":"Antioxid. Redox Signal."},{"key":"57142_CR52","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1083\/jcb.200704110","volume":"178","author":"ZY Song","year":"2007","unstructured":"Song, Z. Y., Chen, H. C., Fiket, M., Alexander, C. & Chan, D. C. OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J. Cell Biol. 178, 749\u2013755 (2007).","journal-title":"J. Cell Biol."},{"key":"57142_CR53","doi-asserted-by":"publisher","unstructured":"Rochette, L. et al. Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis. Int. J. Mol. Sci. 24. https:\/\/doi.org\/10.3390\/ijms24010449 (2022).","DOI":"10.3390\/ijms24010449"},{"key":"57142_CR54","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","volume":"32","author":"J Zheng","year":"2020","unstructured":"Zheng, J. & Conrad, M. The metabolic underpinnings of ferroptosis. Cell Metab. 32, 920\u2013937 (2020).","journal-title":"Cell Metab."},{"key":"57142_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li, J. et al. Ferroptosis: past, present and future. Cell Death Dis. 11, 88 (2020).","journal-title":"Cell Death Dis."},{"key":"57142_CR56","doi-asserted-by":"publisher","first-page":"15835","DOI":"10.1021\/bi981512h","volume":"37","author":"KM Humphries","year":"1998","unstructured":"Humphries, K. M. & Szweda, L. I. Selective inactivation of \u03b1-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry 37, 15835\u201315841 (1998).","journal-title":"Biochemistry"},{"key":"57142_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13124","volume":"33","author":"L Fan","year":"2023","unstructured":"Fan, L. et al. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson\u2019s disease. Brain Pathol. 33, e13124 (2023).","journal-title":"Brain Pathol."},{"key":"57142_CR58","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202317451","volume":"15","author":"S Torii","year":"2023","unstructured":"Torii, S. et al. Involvement of casein kinase 1 epsilon\/delta (Csnk1e\/d) in the pathogenesis of familial Parkinson\u2019s disease caused by CHCHD2. EMBO Mol. Med. 15, e17451 (2023).","journal-title":"EMBO Mol. Med."},{"key":"57142_CR59","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1093\/hmg\/ddz241","volume":"28","author":"A Ikeda","year":"2019","unstructured":"Ikeda, A. et al. Mutations in CHCHD2 cause alpha-synuclein aggregation. Hum. Mol. Genet. 28, 3895\u20133911 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"57142_CR60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/hmg\/ddx393","volume":"27","author":"IR Straub","year":"2018","unstructured":"Straub, I. R. et al. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS. Hum. Mol. Genet. 27, 178\u2013189 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"57142_CR61","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-019-01989-y","volume":"138","author":"CJ Anderson","year":"2019","unstructured":"Anderson, C. J. et al. ALS\/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response. Acta Neuropathol. 138, 103\u2013121 (2019).","journal-title":"Acta Neuropathol."},{"key":"57142_CR62","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/hmg\/ddaa077","volume":"29","author":"YT Liu","year":"2020","unstructured":"Liu, Y. T. et al. Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations. Hum. Mol. Genet. 29, 1547\u20131567 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"57142_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04602-5","volume":"13","author":"Y Ruan","year":"2022","unstructured":"Ruan, Y. et al. CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response. Cell Death Dis. 13, 156 (2022).","journal-title":"Cell Death Dis."},{"key":"57142_CR64","doi-asserted-by":"publisher","unstructured":"Sayles, N. M. et al. Mutant CHCHD10 causes an extensive metabolic rewiring that precedes OXPHOS dysfunction in a murine model of mitochondrial cardiomyopathy. Cell Rep. 38. https:\/\/doi.org\/10.1016\/j.celrep.2022.110475 (2022).","DOI":"10.1016\/j.celrep.2022.110475"},{"key":"57142_CR65","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/hmg\/ddab078","volume":"30","author":"IR Straub","year":"2021","unstructured":"Straub, I. R., Weraarpachai, W. & Shoubridge, E. A. Multi-OMICS study of a CHCHD10 variant causing ALS demonstrates metabolic rewiring and activation of endoplasmic reticulum and mitochondrial unfolded protein responses. Hum. Mol. Genet. 30, 687\u2013705 (2021).","journal-title":"Hum. Mol. Genet."},{"key":"57142_CR66","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"57142_CR67","doi-asserted-by":"publisher","unstructured":"Burbulla, L. F. et al. A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson\u2019s disease. Sci. Transl. Med. 11. https:\/\/doi.org\/10.1126\/scitranslmed.aau6870 (2019).","DOI":"10.1126\/scitranslmed.aau6870"},{"key":"57142_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22113-3","volume":"12","author":"S Kim","year":"2021","unstructured":"Kim, S., Wong, Y. C., Gao, F. & Krainc, D. Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson\u2019s disease. Nat. Commun. 12, 1807 (2021).","journal-title":"Nat. Commun."},{"key":"57142_CR69","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks, S. et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease. Nature 480, 547\u2013551 (2011).","journal-title":"Nature"},{"key":"57142_CR70","doi-asserted-by":"publisher","unstructured":"Schr\u00f6der, L. F. et al. VPS13C regulates phospho-Rab10-mediated lysosomal function in human dopaminergic neurons. J. Cell Biol. 223. https:\/\/doi.org\/10.1083\/jcb.202304042 (2024).","DOI":"10.1083\/jcb.202304042"},{"key":"57142_CR71","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"57142_CR72","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cell.2016.07.040","volume":"166","author":"WW Chen","year":"2016","unstructured":"Chen, W. W., Freinkman, E., Wang, T., Birsoy, K. & Sabatini, D. M. Absolute quantification of matrix metabolites reveals the dynamics of mitochondrial metabolism. Cell 166, 1324\u20131337.e1311 (2016).","journal-title":"Cell"},{"key":"57142_CR73","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1038\/nprot.2017.104","volume":"12","author":"WW Chen","year":"2017","unstructured":"Chen, W. W., Freinkman, E. & Sabatini, D. M. Rapid immunopurification of mitochondria for metabolite profiling and absolute quantification of matrix metabolites. Nat. Protoc. 12, 2215\u20132231 (2017).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57142-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57142-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57142-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T07:16:21Z","timestamp":1740554181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57142-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57142"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57142-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"13 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.K. is the founder and scientific advisory board chair of Vanqua Bio, serves on the scientific advisory boards of The Silverstein Foundation, Intellia Therapeutics, AcureX, and is a venture partner at OrbiMed. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1982"}}